Eli Lilly and Co (LLY) will raise its quarterly dividend by 8.2 percent to $0.5625 per share in the first quarter of 2018. The pharmaceutical company raised its dividend by 2 percent in 2016.
The dividend is payable March 9, 2018, to shareholders of record at of the close of business on February 15, 2018. The ex-date for this next dividend is February 14, 2018. The new annual dividend of $2.25 per share yields 2.6%.
Eli Lilly and Company is a manufacturer of human pharmaceutical products and animal health products. It’s human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The company's Elanco division develops, manufactures and markets products for both food animals and companion animals. Eli Lilly and Company was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly.